KEERAN RAVIN SAMPAT MD NPI 1518103811

NPI Details

Keeran Ravin Sampat, MD is a hematology and oncology internal medicine in Arlington, VA with 21 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Keeran Ravin Sampat, MD NPI is 1518103811. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

1100 N GLEBE RD STE 1600
ARLINGTON, VA
ZIP 22201-798
Phone: (571) 350-8400
Fax: (703) 528-0338

The NPI 1518103811 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Protein measurement, serum (HCPCS:84165)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Unclassified drugs (HCPCS:J3490)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Magnesium level (HCPCS:83735)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Total protein level, blood (HCPCS:84155)
• Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 12/17/2008 and was last updated on 11/12/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.